Follow-up of the Inflammatory Cardiomyopathy Cohort of SFB/TR19
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cardiomyopathies
- Sponsor
- University Medicine Greifswald
- Enrollment
- 150
- Locations
- 1
- Primary Endpoint
- Number of cardiovascular events
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
Follow-up of a cohort of inflammatory cardiomyopathy patients (suspected or validated inflammatory cardiomyopathy) recruited at baseline by the SFB-TR19 project. Standardized protocols will be used for the assessment of medical history and examinations, laboratory biomarkers, and the collection of various biomaterials for biobanking purposes.
Detailed Description
Periodical follow-up of a cohort of inflammatory cardiomyopathy patients (suspected or validated inflammatory cardiomyopathy) recruited at baseline by the SFB/TR19 project. Participants will be followed up at least every year - or more frequently based on clinical need. Standardized protocols will be used for the assessment of medical history and examinations, laboratory biomarkers, and the collection of various biomaterials for biobanking purposes.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participation in baseline examination of SFB/TR19
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Number of cardiovascular events
Time Frame: 1-year follow-ups up to 10 years
Number of hospitalization (HF based. all-cause), interventions (ICD, pacemaker), myocardial infarction
Secondary Outcomes
- VO2peak(1-year follow-ups up to 10 years)
- Mortality(1-year follow-ups up to 10 years)
- LVEF (left ventricular ejection fraction)(1-year follow-ups up to 10 years)
- QOL(1-year follow-ups up to 10 years)